195TiP: Pembrolizumab (MK-3475) versus platinum-based chemotherapy for PD-L1+ NSCLC in a phase 3, randomized, open-label study: KEYNOTE-042

T. Mok, Y. L. Wu, S. Sadowski, J. Zhang, R. Rangwala, D. Kush, G. de Lima Lopes

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)S142
JournalJournal of Thoracic Oncology
Volume11
Issue number4
DOIs
StatePublished - Apr 2016
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this